Navigation Links
Jackson Lewis to Support Presagia's Integrated Absence & Disability Management Solution
Date:2/28/2008

MONTREAL, Feb. 28 /PRNewswire/ -- Jackson Lewis LLP, a leading U.S. workplace law firm and Presagia Corporation, a leading provider of health and productivity management solutions, today announced the signing of an agreement that will see Jackson Lewis assist Presagia with the development of its workforce absence and disability software solutions.

According to David Glickman, Presagia's CEO, "Integrated absence and disability management is widely regarded as an effective strategy to reduce lost-time costs for U.S. employers, currently estimated to be 15% of payroll and growing. Through comprehensive, standardized management and documentation of all leave cases and appropriate escalation of potential high-cost cases, employers can target the primary absence drivers and minimize related health, productivity and legal compliance costs."

"We're very excited to be working with Presagia on this initiative," explains Frank Alvarez, national coordinator for Jackson Lewis' Disability, Leave and Health Management practice group. "Leave management and benefit administration have grown increasingly complex. Employers seem to be starving for tools to help them manage attendance and productivity more effectively. To make good employment decisions that reduce the risk of employment litigation, employers must identify and respect employee eligibility for job-protected leaves; they also must efficiently capture and communicate information about employee medical conditions and absences. Presagia's software will help fulfill those employer needs and we are pleased to be a part of that effort."

While Presagia's technology is not a legal service, and no attorney-client relationship is formed by its purchase or use, Jackson Lewis will help Presagia develop the workflow, rules, documentation and decision support required for compliance and litigation support.

In addition to enhancing workplace compliance efforts and providing accurate and complete docume
'/>"/>

SOURCE Presagia Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. First in Nation: notMYkid Educational Center Is Now a Reality Thanks to a Partnership Between Chrysler, Barrett-Jackson and notMYkid
2. CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville
3. Randy Jackson Takes Aim at Diabetes
4. Randy Jackson and the American Heart Association Promote Awareness about the Connection Between Type 2 Diabetes and Cardiovascular Disease
5. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
6. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
7. IncentOnes Sue Lewis brings "The Art and Science of Incentive Management" to AHIP Business Forum
8. Jerry Lewis Urges Congress to Protect Medicare Benefits of People With Neuromuscular Diseases
9. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
10. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
11. ISS and Glass Lewis Recommend Cholestech Stockholders Vote FOR Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2
... care visits to family doctors are declining, rese...Day News) -- Specialists are increasingly providin...ionally been handled by primary care doctors, a ne... visits for specialized care is for routine and pr...
... Workman proudly touts support of Sam Schmidt Para... While Punch Energy Drink,s well-recognized tagli...orkman, Punch Energy Founder and 21-year-old bever...oday, Workman proudly announced that the Sam Schmi...
...leadership needed to manage growth , , WAYNE, Pa....f clinical documentation software, workflow tools ...and realigning its organization by service and sol...ion Services and James Stewart, Vice President of ...
..., March 10 More physician leaders are embracing t...records, but most still consider them clunky and u...ults found in a recent survey by the American Coll... management. , , ACPE conducted the same survey b...
... March 10 LCA-Vision Inc. (Nasdaq: LCAV ) today...arison of excimer laser platform technologies, the...of platforms at each of its Lasik Plus (R) vision ...ly no later than the end of the third quarter of 2...
...arch 10, 2009 Forest Laboratories, Inc. (NYSE: ...rma GmbH & Co. KGaA, and Merz Pharmaceuticals ...emark Office has issued a Notice of Final Determin... Administration Orange Book for NAMENDA(R) (memant...
Other Medicine News:Health News:For Primary Care, More Patients Are Seeing Specialists 2Health News:For Primary Care, More Patients Are Seeing Specialists 3Health News:Punch Energy Drink Announces Recipient of Its Inaugural LIVE BETTER AWARD(R) 2Health News:Punch Energy Drink Announces Recipient of Its Inaugural LIVE BETTER AWARD(R) 3Health News:Precyse Solutions Adds Executives, Realigns Around Service Lines 2Health News:Survey Results: Health Care Technology Advances as Physician Frustration Grows 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 2Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 3Health News:LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually 4Health News:USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA(R) 2
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 1Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 2Echo Therapeutics Announces Significant Advance in Development of its One Piece Needle Free Symphony tCGM Biosensor 5825 3Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 1Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 2Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 3Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 4Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 5Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 6Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 7Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 8Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 9Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 10Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 11Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 12Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 13Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 14Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full Year Financial Guidance 5820 15Dr Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 5815 1Dr Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 5815 2Dr Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics 5815 3
...S, Oct. 26 The complex cases performed,during thi... Therapeutics,symposium by Dr. Tony Das, an interv...Dallas, represent the latest treatments for periph... the U.S. population ages and more,Americans live ... will also,dramatically increase the number of peo...
...SLEY, Mass., Oct. 26 Coley,Pharmaceutical Group, ...mpany,has received a $3.0 million milestone paymen...nitiation of GSK,s Phase III clinical trial in,non...eutic cancer vaccine,containing Coley,s VaxImmune(... the launch of the largest Phase III,clinical tria...
Other Medicine Technology:Cardiologists Tackle 'Next Frontier' in Cardiovascular Disease 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 3
High Lite Convertible
High Lite Classic
High Beam Classic
...nalyzer is a semi-automated benchtop instrument fo...nQuick is designed to analyze and generate results...k 8+ urine test strips. The UrinQuick analyzes the...y. Test results are available in conventional, S.I...
Medicine Products: